Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci

被引:16
|
作者
da Silva, Natal Santos [1 ,2 ]
Muniz, Vitor Dantas [3 ]
Estofolete, Cassia Fernanda [3 ,4 ]
Campos Furtado, Guilherme Henrique [5 ]
Rubio, Fernando Gongora [3 ]
机构
[1] Med Coll Sao Jose do Rio Preto, Postgrad Dept, Sao Paulo, Brazil
[2] Union Coll Great Lakes, Coll Med, Dept Med Sci, Sao Paulo, Brazil
[3] Hosp Base, Dept Infect & Parasit Dis, Sao Paulo, Brazil
[4] Med Coll Sao Jose do Rio Preto, Virol Lab, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Dept Infect Dis, Hosp Epidemiol Comm, Sao Paulo, Brazil
关键词
Cohort study; Sepsis; Antibiotic; Resistance profile; EPIDEMIOLOGY; ACQUISITION; INFECTIONS; MORTALITY; OUTCOMES;
D O I
10.1016/j.ajic.2013.11.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study aimed to evaluate a different methodology for addressing the evolution of nosocomial bacteremia by vancomycin-resistant enterococci (VRE) in a hospital setting. Methods: In this retrospective cohort study, data were collected from the date of first registration up to December 2008 from the electronic medical records of patients with VRE bacteremia in a school hospital. Results: Thirty cases of VRE bacteremia and 274 cases of vancomycin-susceptible enterococci (VSE) bacteremia were identified. The average age of the patients was 56 years. The rates of Enterococcus faecium and Enterococcus faecalis in the hospital's intensive care unit (ICU) and wards showed no statistically significant differences. The risk of acquiring VRE bacteremia was at least 3-fold higher in the ICU than in the wards. The risk of death was 2.73-fold higher in patients with VRE bacteremia compared with those with VSE bacteremia. Only one temporal cluster statistically significant of VRE bacteremia was found in the study period. Conclusions: The identification of temporal clusters can be an important tool to optimize health actions and thereby reduce the burden of operating costs. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 392
页数:4
相关论文
共 50 条
  • [1] Nosocomial transmission of vancomycin-resistant enterococci from surfaces
    Ray, AJ
    Hoyen, CK
    Taub, TF
    Eckstein, EC
    Donskey, CJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1400 - 1401
  • [2] Vancomycin-resistant enterococci bacteremia: Risk factors for mortality and influence of antimicrobial therapy on clinical outcome
    Han, Sang Hoon
    Chin, Bum Sik
    Lee, Han Sung
    Jeong, Su Jin
    Choi, Hee Kyoung
    Kim, Chang Oh
    Yong, Dongeun
    Choi, Jun Yong
    Song, Young Goo
    Lee, Kyungwon
    Kim, June Myung
    JOURNAL OF INFECTION, 2009, 58 (03) : 182 - 190
  • [3] Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci
    Harbarth, S
    Cosgrove, S
    Carme, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1619 - 1628
  • [4] Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults
    Monteserin, N.
    Larson, E.
    JOURNAL OF HOSPITAL INFECTION, 2016, 94 (03) : 236 - 241
  • [5] Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
    Kara, Ahu
    Devrim, Ilker
    Bayram, Nuri
    Katipoglu, Nagehan
    Kiran, Ezgi
    Oruc, Yeliz
    Demiray, Nevbahar
    Apa, Hursit
    Gulfidan, Gamze
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (01): : 58 - 61
  • [6] Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital
    MacIntyre, CR
    Empson, M
    Boardman, C
    Sindhusake, D
    Lokan, J
    Brown, GV
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (10): : 624 - 629
  • [7] Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
    Puchter, Laura
    Chaberny, Iris Freya
    Schwab, Frank
    Vonberg, Ralf-Peter
    Bange, Franz-Christoph
    Ebadi, Ella
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [8] Vancomycin-resistant enterococci
    Palmer, SM
    Rybak, MJ
    PHARMACOTHERAPY, 1996, 16 (05): : 819 - 829
  • [9] Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
    Laura Puchter
    Iris Freya Chaberny
    Frank Schwab
    Ralf-Peter Vonberg
    Franz-Christoph Bange
    Ella Ebadi
    Antimicrobial Resistance & Infection Control, 7
  • [10] Vancomycin-resistant enterococci
    Looke, D
    NEPHROLOGY, 2002, 7 : S67 - S68